Resection of colorectal liver metastases: Current perspectives

Cancer Control

Volumn 13, Issue 1, 2006, Pages 32-41

  McLoughlin, James M ^a   Jensen, Eric H ^a   Malafa, Mokenge ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ACUTE KIDNEY FAILURE; ADJUVANT THERAPY; ANAMNESIS; ARTERY INJURY; ARTIFICIAL EMBOLISM; BILE DUCT FISTULA; BILE LEAKAGE; BILIARY TRACT DISEASE; BLOOD CLOTTING DISORDER; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CRYOTHERAPY; DECISION MAKING; DIAPHRAGM MUSCLE; DISEASE SEVERITY; FATTY LIVER; FEVER; FOLLOW UP; FREEZING; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEMATOMA; HEPATIC ARTERY; HUMAN; IMAGING; KIDNEY FAILURE; LAPAROSCOPY; LIVER ABSCESS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER INJURY; LIVER METASTASIS; LIVER PARENCHYMA; MORBIDITY; MYOGLOBINURIA; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PATIENT SELECTION; PEROPERATIVE ECHOGRAPHY; PLEURA EFFUSION; PORTAL PHLEBOGRAPHY; PORTAL VEIN; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; SHOCK; SURGICAL ANATOMY; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

EID: 33644638369     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327480601300105     Document Type: Review

References (128)

1. Jemal A, Ward E, Hao Y, et al. Trends in the leading causes of death in the United States, 1970-2002. JAMA. 2005;294:1255-1259.
2. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
3. Erratum in: CA Cancer J Clin. 2005;55:259.
4. Wilson SM, Adson MA. Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg. 1976;111:330-334.
5. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol. 1997;15:938-946.
6. Kemeny N, Jarnagin W, Gonen M, et al. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol. 2003;21:3303-3309.
7. Bentrem DJ, Dematteo RP, Blumgart LH. Surgical therapy for metastatic disease to the liver. Annu Rev Med. 2005;56:139-156.
8. Keen WW. Removal of an angioma of the liver by elastic constriction external to the abdominal cavity, with a table of 59 cases of operation for hepatic tumors. Pa Med J. 1897;1:198.
9. Foster JH. Survival after liver resection for secondary tumors. Am J Surg. 1978;135:389-394.
10. Wagner JS, Adson MA, Van Heerden JA, et al. The natural history of hepatic metastases from colorectal cancer: a comparison with resective treatment. Ann Surg. 1984;199:502-508.
11. Adson MA, van Heerden JA, Adson MH, et al. Resection of hepatic metastases from colorectal cancer. Arch Surg. 1984;119:647-651.
12. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery. 1986;100:278-284.
13. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg. 1990;77:1241-1246.
14. Schlag P, Hohenberger P, Herfarth C. Resection of liver metastases in colorectal cancer: competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol. 1990;16:360-365.
15. Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg. 1992;216:493-505.
16. Gayowski TJ, Iwatsuki S, Madariaga JR, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery. 1994;116:703-711.
17. Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg. 1995;19:59-71.
18. Jamison RL, Donohue JH, Nagorney DM, et al. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg. 1997;132:505-511.
19. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309-321.
20. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759-766.
21. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818-827.
22. Mutsaerts EL, van Ruth S, Zoetmulder FA, et al. Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: a 10-year single-institute experience. J Gastrointest Surg. 2005;9:178-186.
23. Woodington GF, Waugh JM. Results of resection of metastatic tumors of the liver. Am J Surg. 1963;105:24-29.
24. Pestana C, Reitemeier RJ. Moertel CG, et al. The natural history of carcinoma of the colon and rectum. Am J Surg. 1964;108:826-829.
25. Cady B, Monson DO, Swinton NW. Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet. 1970;131:697-700.
26. Lahr CJ, Soong SJ, Cloud G, et al. A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol. 1983;1:720-726.
27. Adson MA. Resection of liver metastases: when is it worthwhile? World J Surg. 1987;11:511-520.
28. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol. 1976;2:285-288.
29. Stangl R, Altendorf-Hofmann A, Charnley RM, et al. Factors influencing the natural history of colorectal liver metastases. Lancet. 1994;343:1405-1410.
30. Rougier P, Milan C, Lazorthes F, et al. Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Francaise de Cancerologie Digestive. Br J Surg. 1995;82:1397-1400.
31. Scheele J, Altendorf-Hofmann A, Grube T, et al. Resection of colorectal liver metastases: what prognostic factors determine patient selection? [in German] Chirurg. 2001;72:547-560.
32. Kato T, Yasui K, Hirai T, et al. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum. 2003;46:S22-S31.
33. Scheele J, Altendorf-Hofmann A. Resection of colorectal liver metastases. Langenbecks Arch Surg. 1999;384:313-327.
34. Leonard GD, Brenner B, Kemeny NE, et al. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2005;23:2038-2048.
35. Jaffe BM, Donegan WL, Watson F, et al. Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet. 1968;127:1-11.
36. Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer. 1969;23:198-202.
37. Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2004;22:23-30. Epub 2003 Dec 9.
38. Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2004;22:229-237. Epub 2003 Dec 2.
39. Moertel CG, Gunderson LL, Mailliard JA, et al. Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group. J Clin Oncol. 1994;12:21-27.
40. Wanebo HJ, Semoglou C, Attiyeh F, et al. Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg. 1978;135:81-85.
41. Heslin MJ, Medina-Franco H, Parker M, et al. Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival. Arch Surg. 2001;136:318-323.
42. Erratum in: Arch Surg. 2001;136:809.
43. Luna-Perez P, Rodriguez-Coria DF, Arroyo B, et al. The natural history of liver metastases from colorectal cancer. Arch Med Res. 1998;29:319-324.
44. Suzuki S, Sakaguchi T, Yokoi Y, et al. Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery. 2001;129:421-428.
45. Muratore A, Polastri R, Bouzari H, et al. Repeat hepatectomy for colorectal liver metastases: a worthwhile operation? J Surg Oncol. 2001;76:127-132.
46. Tuttle TM, Curley SA, Roh MS. Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases. Ann Surg Oncol. 1997;4:125-130.
47. Fernandez-Trigo V, Shamsa F, Sugarbaker PH. Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry. Surgery. 1995;117:296-304.
48. Fong Y, Blumgart LH, Cohen A, et al. Repeat hepatic resections for metastatic colorectal cancer. Ann Surg. 1994;220:657-662.
49. Nordlinger B, Vaillant JC, Guiguet M, et al. Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. J Clin Oncol. 1994;12:1491-1496.
50. Vaillant JC, Balladur P, Nordlinger B, et al. Repeat liver resection for recurrent colorectal metastases. Br J Surg. 1993;80:340-344.
51. Bozzetti F, Bignami P, Montalto F, et al. Repeated hepatic resection for recurrent metastases from colorectal cancer. Br J Surg. 1992;79:146-148.
52. Hohenberger P, Schlag P, Schwarz V, et al. Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer. J Surg Oncol. 1990;44:245-251.
53. DeMatteo RP, Palese C, Jarnagin WR, et al. Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg. 2000;4:178-184.
54. Petrowsky H, Gonen M, Jarnagin W, et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg. 2002;235:863-871.
55. Adam R, Bismuth H, Castaing D, et al. Repeat hepatectomy for colorectal liver metastases. Ann Surg. 1997;225:51-62.
56. Yamamoto J, Kosuge T, Shimada K, et al. Repeat liver resection for recurrent colorectal liver metastases. Am J Surg. 1999;178:275-281.
57. Hughes KS, Rosenstein RB, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of longterm survivors. Dis Colon Rectum. 1988;31:1-4.
58. Nordlinger B, Peschaud F, Malafosse R. Resection of liver metastases from colorectal cancer: how can we improve results? Colorectal Dis. 2003;5:515-517.
59. Doci R, Gennari L, Bignami P, et al. Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg. 1995;82:377-381.
60. Matsumata T, Taketomi A, Kawahara N, et al. Morbidity and mortality after hepatic resection in the modern era. Hepatogastroenterology. 1995;42:456-460.
61. 2006 National Comprehensive Cancer Network. Available at: http://www.nccn.com. Accessed on December 29, 2005.
62. Rogers LF. "My word, what is that?" Hounsfield and the triumph of clinical research. AJR Am J Roentgenol. 2003;180:1501.
63. Li L, Wu PH, Mo YX, et al. CT arterial portography and CT hepatic arteriography in detection of micro liver cancer. World J Gastroenterol. 1999;5:225-227.
64. Schmidt J, Strotzer M, Fraunhofer S, et al. Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: lesion-by-lesion analysis. World J Surg. 2000;24:43-48.
65. Sahani DV, Kalva SP. Imaging the liver. Oncologist. 2004;9:385-397.
66. Park JH, Nazarian LN, Halpern EJ, et al. Comparison of unenhanced and contrast-enhanced spiral CT for assessing interval change in patients with colorectal liver metastases. Acad Radiol. 2001;8:698-704.
67. Okano K, Yamamoto J, Okabayashi T, et al. CT imaging of intrabiliary growth of colorectal liver metastases: a comparison of pathological findings of resected specimens. Br J Radiol. 2002;75:497-501.
68. Valls C, Andia E, Sanchez A, et al. Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. Radiology. 2001;218:55-60.
69. Saini S. Imaging of the hepatobiliary tract. N Engl J Med. 1997;336:1889-1894.
70. Kamel IR, Bluemke DA. MR imaging of liver tumors. Radiol Clin North Am. 2003;41:51-65.
71. Vogl TJ, Schwarz W, Blume S, et al. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol. 2003;13:262-272. Epub 2002 Sep 10.
72. Semelka RC, Cance WG, Marcos HB, et al. Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology. 1999;213:86-91.
73. Yang M, Martin DR, Karabulut N, et al. Comparison of MR and PET imaging for the evaluation of liver metastases. J Magn Reson Imaging. 2003;17:343-349.
74. Truant S, Huglo D, Hebbar M, et al. Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg. 2005;92:362-369.
75. Johnson K, Bakhsh A, Young D, et al. Correlating computed tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer. Dis Colon Rectum. 2001;44:354-357.
76. Fong Y, Saldinger PF, Akhurst T, et al. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg. 1999;178:282-287.
77. Boykin KN, Zibari GB, Lilien DL, et al. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Am Surg. 1999;65:1183-1185.
78. Zealley IA, Skehan SJ, Rawlinson J, et al. Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet. Radiographics. 2001;21:S55-S69.
79. Grobmyer SR, Fong Y, D'Angelica M, et al. Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases. Arch Surg. 2004;139:1326-1330.
80. Catheline JM, Turner R, Champault G. Laparoscopic ultrasound of the liver. Eur J Ultrasound. 2000;12:169-177.
81. Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996;224:509-520; discussion 520-522.
82. Ekberg H, Tranberg KG, Andersson R, et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg. 1986;73:727-731.
83. Yamaguchi J, Yamamoto M, Komuta K, et al. Hepatic resections for bilobar liver metastases from colorectal cancer. J Hepatobiliary Pancreat Surg. 2000;7:404-409.
84. Hughes K, Scheele J, Sugarbaker PH. Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am. 1989;69:339-359.
85. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 1996;77:1254-1262.
86. Wray CJ, Lowy AM, Mathews JB, et al. The significance and clinical factors associated with a subcentimeter resection of colorectal liver metastases. Ann Surg Oncol. 2005;12:374-380. Epub 2005 Mar 29.
87. Elias D, Debaere T, Muttillo I, et al. Intraoperative use of radiofrequency treatment allows an increase in the rate of curative liver resection. J Surg Oncol. 1998;67:190-191.
88. Wallace JR, Christians KK, Pitt HA, et al. Cryotherapy extends the indications for treatment of colorectal liver metastases. Surgery. 1999;126:766-774
89. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
90. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol. 2005;16:481-488. Epub 2005 Feb 17.
91. Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer. 2002;38:1023-1033.
92. Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg. 2003;197:233-242.
93. Vogt P, Raab R, Ringe B, et al. Resection of synchronous liver metastases from colorectal cancer. World J Surg. 1991;15:62-67.
94. Scheele J, Stangl R, Altendorf-Hofmann A, et al. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery. 1991;110:13-29.
95. Jenkins LT, Millikan KW, Bines SD, et al. Hepatic resection for metastatic colorectal cancer. Am Surg. 1997;63:605-610.
96. Elias D, Detroz B, Lasser P, et al. Is simultaneous hepatectomy and intestinal anastomosis safe? Am J Surg. 1995;169:254-260.
97. Jaeck D, Bachellier P, Weber JC, et al. Surgical treatment of synchronous hepatic metastases of colorectal cancers. Simultaneous or delayed resection [French]? Ann Chir. 1996;50:507-16.
98. Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg. 2000;231:743-751.
99. Fujita S, Akasu T, Moriya Y. Resection of synchronous liver metastases from colorectal cancer. Jpn J Clin Oncol. 2000;30:7-11.
100. Lyass S, Zamir G, Matot I, et al. Combined colon and hepatic resection for synchronous colorectal liver metastases. J Surg Oncol. 2001;78:17-21.
101. Morris DL. Surgery for liver metastases: how many? ANZ J Surg. 2002;72:2.
102. Asbun HJ, Tsao JI, Hughes KS. Resection of hepatic metastases from colorectal carcinoma: the registry data. Cancer Treat Res. 1994;69:33-41.
103. Levitan N, Hughes KS. Management of non-resectable liver metastases from colorectal cancer. Oncology (Williston Park). 1990;4:77-84, 89, 92.
104. Poston GJ. Surgical strategies for colorectal liver metastases. Surg Oncol. 2004;13:125-136.
105. Poston GJ, Adam R, Alberts S, et al. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol. 2005;23:7125-7134.
106. Primrose JN. Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation. Gut. 2002;50:1-5.
107. Berney T, Mentha G, Morel P. Total vascular exclusion of the liver for the resection of lesions in contact with the vena cava or the hepatic veins. Br J Surg. 1998;85:485-488.
108. Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 1999;341:2039-2048.
109. Lorenz M, Staib-Sebler E, Hochmuth K, et al. Surgical resection of liver metastases of colorectal carcinoma: short and long-term results. Semin Oncol. 2000;27(5 Suppl 10):112-119.
110. Giacchetti S, Itzhaki M, Gruia G, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol. 1999;10:663-669.
111. Adam R, Avisar E, Ariche A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol. 2001;8:347-353.
112. Wein A, Riedel C, Kockerling F, et al. Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid. Ann Oncol. 2001;12:1721-1727.
113. Rivoire M, De Cian F, Meeus P, et al. Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma. Cancer. 2002;95:2283-2292.
114. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:644-657.
115. Pozzo C, Basso M, Cassano A, et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol. 2004;15:933-939.
116. Delaunoit T, Alberts SR, Sargent DJ, et al. Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol. 2005;16:425-429. Epub 2005 Jan 27.
117. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346:1128-1137.
118. Feliberti EC, Wagman LD. Radiofrequency ablation of liver metastases from colorectal cancer: where we are. Cancer Control. 2006;13:48-51.
119. Pearson AS, Izzo F, Fleming RY, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg. 1999;178:592-599.
120. Wong SL, Edwards MJ, Chao C, et al. Radiofrequency ablation for unresectable hepatic tumors. Am J Surg. 2001;182:552-557.
121. Machi J. Radiofrequency ablation for multiple hepatic metastases. Ann Surg Oncol. 2001;8:379-380.
122. Bilchik AJ, Wood TF, Allegra DP. Radiofrequency ablation of unresectable hepatic malignancies: lessons learned. Oncologist. 2001;6:24-33.
123. Gruenberger T, Jourdan JL, Zhao J, et al. Reduction in recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases. Arch Surg. 2001;136:1154-1157.
124. Seifert JK, Morris DL. Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer. Br J Surg. 1999;86:234-240.
125. Ruers TJ, Joosten J, Jager GJ, et al. Long-term results of treating hepatic colorectal metastases with cryosurgery. Br J Surg. 2001;88:844-849.
126. Metcalfe MS, Mullin EJ, Maddern GJ. Choice of surveillance after hepatectomy for colorectal metastases. Arch Surg. 2004;139:749-754.
127. Metcalfe M, Mann C, Mullin E, et al. Detecting curable disease following hepatectomy for colorectal metastases. ANZ J Surg. 2005;75:524-527.
128. Pfister DG, Benson AB 3rd, Somerfield MR. Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. N Engl J Med. 2004;350:2375-2382.